+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Erythropoiesis Stimulating Agent"

From
From
Anemia and Other Blood Disorder Drugs Market Report 2025 - Product Thumbnail Image

Anemia and Other Blood Disorder Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Darbepoetin Alfa (Aranesp) Market Report 2025 - Product Thumbnail Image

Darbepoetin Alfa (Aranesp) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Anemia Drugs Global Market Report 2025 - Product Thumbnail Image

Anemia Drugs Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Roxadustat Global Market Report 2025 - Product Thumbnail Image

Roxadustat Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Myelofibrosis (MF) Global Market Report 2025 - Product Thumbnail Image

Myelofibrosis (MF) Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Anemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Anemia Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 383 Pages
  • Global
From
Anemia In Chronic Kidney- Pipeline Insight, 2025 - Product Thumbnail Image

Anemia In Chronic Kidney- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Iron Deficiency Anemia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Iron Deficiency Anemia Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Renal Anemia Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Renal Anemia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
Epoetin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Epoetin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Anti-anemic Drug Market - Forecasts from 2020 to 2025 - Product Thumbnail Image

Anti-anemic Drug Market - Forecasts from 2020 to 2025

  • Report
  • April 2020
  • 125 Pages
  • Global
From
Loading Indicator

Erythropoiesis Stimulating Agents (ESAs) are a class of drugs used to treat anemia, a condition in which the body does not produce enough red blood cells. ESAs stimulate the production of red blood cells in the bone marrow, increasing the amount of oxygen-carrying hemoglobin in the blood. ESAs are used to treat anemia caused by chemotherapy, chronic kidney disease, and other conditions. They are also used to reduce the need for blood transfusions in certain patients. ESAs are a major component of the hematological drugs market, which includes drugs used to treat blood-related diseases and disorders. The market is driven by the increasing prevalence of anemia and other blood-related disorders, as well as the development of new drugs and treatments. Some companies in the ESA market include Amgen, Johnson & Johnson, Roche, Novartis, and Pfizer. Show Less Read more